Athersys to Host Fourth Quarter and Year-End 2012 Financial Results Call

Athersys to Host Fourth Quarter and Year-End 2012 Financial Results Call

CLEVELAND, Feb. 25, 2013 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX)
today announced it will release its fourth quarter and year-end 2012 financial
results at approximately 4:00 PM (Eastern Time) on Tuesday, March 12, 2013,
and host a conference call shortly thereafter at 4:30 PM (Eastern Time) to
review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer,
and William (B.J.) Lehmann, President and Chief Operating Officer, will host
the call as follows:

Date                              March 12, 2013
Time                              4:30 p.m. (Eastern Time)
Telephone access: U.S. and Canada 800-273-1254
Telephone access: International   973-638-3440
Access code                       95456637
Live webcast            , under the Investors

A replay will be available for on-demand listening shortly after the
completion of the call until 11:59 PM (Eastern Time) on March 28, 2013, at the
aforementioned URL, or by dialing 800-585-8367 or 855-859-2056 in the U.S. and
Canada, from abroad, 404-537-3406, and entering access code 95456637.

About Athersys

Athersys is a clinical stage biotechnology company engaged in the discovery
and development of therapeutic product candidates designed to extend and
enhance the quality of human life. The Company is developing its MultiStem^®
cell therapy product, a patented, adult-derived "off-the-shelf" stem cell
product platform for disease indications in the cardiovascular, neurological,
inflammatory and immune disease areas. The Company currently has several
clinical stage programs involving MultiStem, including for treating
inflammatory bowel disease, ischemic stroke, damage caused by myocardial
infarction, and for the prevention of graft-versus-host disease. Athersys has
also developed a diverse portfolio that includes other technologies and
product development opportunities, and has forged strategic partnerships and
collaborations with leading pharmaceutical and biotechnology companies, as
well as world-renowned research institutions in the United States and Europe
to further develop its platform and products. More information is available at

The Athersys, Inc. logo is available at

CONTACT: William (B.J.) Lehmann, J.D.
         President and Chief Operating Officer
         Tel: (216) 431-9900
         Investor Relations:
         Lisa M. Wilson
         In-Site Communications
         Tel: (917) 543-9932

company logo
Press spacebar to pause and continue. Press esc to stop.